News/ News/ R&D FDA clears US trials of Green Valley’s Alzheimer’s drug Richard Staines aducanumab, Alzheimer's, Biogen, Green Valley, Oligomannate, R&D 0 Comment China’s Shanghai Green Valley Pharmaceuticals has clearance to begin a late stage clinical trial to support a US filing Share X FDA clears US trials of Green Valley’s Alzheimer’s drug https://pharmaphorum.com/news/fda-clears-us-trials-of-green-valleys-of-alzheimers-drug/
News/ News/ R&D Chinese pharma claims first Alzheimer’s drug approval since 2003 Richard Staines Alzheimer's, Green Valley, Oligomannate 0 Comment China’s drugs regulator has conditionally approved Shanghai Green Valley Pharmaceuticals’ Oligomannate to improve cognitive function in mild to Share X Chinese pharma claims first Alzheimer’s drug approval since 2003 https://pharmaphorum.com/news/chinas-shanghai-green-valley-claims-first-alzheimers-approval-since-2003/
aducanumab, Alzheimer's, Biogen, Green Valley, Oligomannate, R&D
0 Comment
